MARKET

SVA

SVA

Sinovac Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.47
0.00
0.00%
Suspension 16:00 06/24 EDT
OPEN
--
PREV CLOSE
6.47
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
6.58
52 WEEK LOW
6.25
MARKET CAP
639.90M
P/E (TTM)
88.15
1D
5D
1M
3M
1Y
5Y
Thailand to try alternative COVID-19 vaccination method to stretch supplies
reuters.com · 1d ago
Cambodia starts coronavirus vaccinations for young children
reuters.com · 4d ago
Hong Kong Tests Boosters for Sinovac Shot as Protection Ebbs
Bloomberg · 4d ago
UPDATE 1-Hong Kong panel advises single dose of BioNTech COVID shot for teens
reuters.com · 5d ago
UPDATE 1-China has completed vaccinating over 70% of its population against COVID-19 - data
reuters.com · 5d ago
UPDATE 2-China should consider vaccinating children aged under 12 against COVID - China CDC expert
reuters.com · 5d ago
Sinovac’s South African Partner Plans Local Shots by Year-End
Bloomberg · 5d ago
Hong Kong panel recommends single dose of BioNTech's COVID-19 shot for teenagers
reuters.com · 5d ago
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SVA. Analyze the recent business situations of Sinovac Biotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
+0.74%
Key Executives
Chairman/Chief Executive Officer/President/Secretary/Director
WeiDong Yin
Chief Financial Officer/Vice President
Nan Wang
Chief Operating Officer/Vice President
Qiang Gao
Vice President
Jing Li
Independent Director
Simon Anderson
Independent Director
Shan Fu
Independent Director
Kenneth Lee
Independent Director
Yuk Lam Lo
Independent Director
Meng Mei
No Data
About SVA
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Webull offers kinds of Sinovac Biotech Ltd. stock information, including NASDAQ:SVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SVA stock methods without spending real money on the virtual paper trading platform.